Cancer experts are increasingly optimistic about the potential for antibody-drug conjugates to become a standard treatment approach. The therapies involve attaching chemotherapy to an antibody to deliver targeted doses of chemo to cancer cells, with fewer side effects.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
